K963005

Substantially Equivalent

NOVA 16 ANALYZER (MODIFICATION POINT OF CARE USAGE)

Applicant: Nova Biomedical Corp.
Product code: JFL
Advisory panel: Clinical Chemistry
Date received: 1996-08-02
Decision date: 1996-08-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walham, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.